Health Care & Life Sciences » Pharmaceuticals | Nichi-iko Pharmaceutical Co. Ltd.

Nichi-iko Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
21,696
14,032
28,179
12,457
18,529
42,093
Total Accounts Receivable
27,857
21,445
24,910
32,697
32,087
30,107
Inventories
32,648
42,429
45,340
67,962
74,321
66,783
Other Current Assets
1,371
1,892
3,195
2,440
3,339
3,737
Total Current Assets
83,572
79,798
101,624
115,558
128,278
142,722
Net Property, Plant & Equipment
29,750
34,107
38,786
47,417
54,045
55,710
Total Investments and Advances
8,421
13,540
8,611
4,657
6,380
18,717
Long-Term Note Receivable
1,932
6,375
4,619
-
-
-
Intangible Assets
3,563
4,652
6,479
90,617
84,271
89,613
Other Assets
1,404
1,362
519
7,883
4,061
64
Total Assets
129,130
139,834
161,128
268,900
278,364
306,838
ST Debt & Current Portion LT Debt
16,334
7,652
19,443
38,189
36,493
Accounts Payable
22,935
32,755
30,193
39,599
39,423
Income Tax Payable
729
2,525
3,813
339
1,676
Other Current Liabilities
6,723
8,686
10,813
15,236
19,802
Total Current Liabilities
46,721
51,618
64,262
93,363
97,394
Long-Term Debt
12,592
9,332
10,464
80,731
87,856
Provision for Risks & Charges
3,345
3,463
3,467
3,578
521
Deferred Taxes
220
925
159
2,461
1,497
Other Liabilities
9
9
7
2,827
2,225
Total Liabilities
62,935
65,347
78,531
185,725
190,819
Common Equity (Total)
66,195
74,487
82,597
83,171
87,542
Total Shareholders' Equity
66,195
74,487
82,597
83,171
87,542
Total Equity
66,195
74,487
82,597
83,171
87,542
Liabilities & Shareholders' Equity
129,130
139,834
161,128
268,896
278,361

About Nichi-iko Pharmaceutical Co.

View Profile
Address
1-6-21 Sogawa
Toyama Toyama 930
Japan
Employees -
Website http://www.nichiiko.co.jp
Updated 07/08/2019
Nichi-Iko Pharmaceutical Co., Ltd. develops, manufactures, and markets generic pharmaceutical products. Its products are classified into Prescriptive and General Over-the-Counter (OTC) drugs. These products are used for the treatment of circulatory, digestive, respiratory, central and peripheral nervous systems problems.